We are live on ! Find out more
AKTX

Akari Therapeutics
AKTX

9 hedge funds and large institutions have $3.97M invested in Akari Therapeutics in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0% → 0% (-0%)

50% less funds holding

Funds holding: 18 → 9 (-9)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

76% less capital invested

Capital invested by funds: $16.8M → $3.97M (-$12.8M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 9

Holders
9
Holders Change
-9
Holders Change %
-50%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
3
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HP
Hikari Power
Japan
+$1.31M

Top Sellers

Rank Fund Capital Flow
1
AIC
AWM Investment Company
New York
-$2.96M
2
VMI
VHCP Management II
New York
-$1.85M
3
UOC
UBS O'Connor
Illinois
-$1.29M
4
DM
Deerfield Management
New York
-$1.08M
5
BBA
Baker Bros. Advisors
New York
-$963K
Name Holding Trade Value Shares
Change 		Change in
Stake
HP
1
Hikari Power
Japan
$1.16M +$1.31M +606 +321%
NMC
2
NEA Management Company
Maryland
$823K – – –
VC
3
Vivo Capital
California
$629K – – –
BBA
4
Baker Bros. Advisors
New York
$618K -$963K -446 -51%
ECM
5
Endurant Capital Management
California
$359K -$8.64K -4 -2%
Millennium Management
6
Millennium Management
New York
$311K -$242K -112 -34%
Bank of Montreal
7
Bank of Montreal
Ontario, Canada
$55K – – –
Parallax Volatility Advisers
8
Parallax Volatility Advisers
California
$14K – – –
IA
9
IFP Advisors
Florida
$4K – – –
AIC
10
AWM Investment Company
New York
– -$2.96M -855 Closed
VMI
11
VHCP Management II
New York
– -$1.85M -533 Closed
UOC
12
UBS O'Connor
Illinois
– -$1.29M -372 Closed
DM
13
Deerfield Management
New York
– -$1.08M -312 Closed
OAM
14
Oxford Asset Management
United Kingdom
– -$159K -45 Closed
Barclays
15
Barclays
United Kingdom
– -$114K -33 Closed
HNB
16
Huntington National Bank
Ohio
– -$35K -10 Closed
Deutsche Bank
17
Deutsche Bank
Germany
– -$13K -4 Closed
First Manhattan
18
First Manhattan
New York
– -$1K -1 Closed

AKTX Hedge Fund Activity: Q1 2018 in Review

9 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Akari Therapeutics (AKTX) for Q1 2018, worth a combined $3.97M — down 76% from $16.8M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of AKTX and 0 opened new positions — a net loss of 9 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was Hikari Power, adding an estimated $1.31M. The largest seller was AWM Investment Company, exiting entirely with an estimated $2.96M sold.

  • 9 institutional investors held Akari Therapeutics (AKTX) as of Q1 2018, down from 18 in Q4 2017.
  • Funds reported $3.97M of Akari Therapeutics stock for Q1 2018, down 76% quarter-over-quarter.
  • 0 funds opened new Akari Therapeutics positions in Q1 2018 and 9 closed out, a net change of -9 holders.
  • The largest Akari Therapeutics buyer in Q1 2018 was Hikari Power, an estimated $1.31M added.
  • The largest Akari Therapeutics seller in Q1 2018 was AWM Investment Company, an estimated $2.96M sold.

Based on aggregated 13F filings for Q1 2018.